BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND NTRK3, TRKC, 4916, ENSG00000140538, Q16288, gp145 trkC AND Treatment
14 results:

  • 1. Macrofollicular Architecture in Invasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Pitfall in Thyroid Practice.
    Yadav S; Kandasamy D; Damle N; Goel R; Chumber S; Sharma MC; Boruah M; Agarwal S
    Head Neck Pathol; 2023 Dec; 17(4):899-909. PubMed ID: 37775618
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A Two-Step Diagnostic Approach for NTRK Gene Fusion Detection in Biliary Tract and Pancreatic Adenocarcinomas.
    Demols A; Rocq L; Perez-Casanova L; Charry M; De Nève N; Ramadhan A; Van Campenhout C; De Clercq S; Maris C; Closset J; Lucidi V; Salmon I; D'Haene N
    Oncologist; 2023 Jul; 28(7):e520-e525. PubMed ID: 36994874
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinicopathological significance of major fusion oncogenes in papillary thyroid carcinoma: An individual patient data meta-analysis.
    Vuong HG; Le HT; Le TTB; Le T; Hassell L; Kakudo K
    Pathol Res Pract; 2022 Dec; 240():154180. PubMed ID: 36306725
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Fusion Oncogenes Are Associated With Increased Metastatic Capacity and Persistent Disease in Pediatric Thyroid cancers.
    Franco AT; Ricarte-Filho JC; Isaza A; Jones Z; Jain N; Mostoufi-Moab S; Surrey L; Laetsch TW; Li MM; DeHart JC; Reichenberger E; Taylor D; Kazahaya K; Adzick NS; Bauer AJ
    J Clin Oncol; 2022 Apr; 40(10):1081-1090. PubMed ID: 35015563
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Diverse Oncogenic Fusions and Distinct Gene Expression Patterns Define the Genomic Landscape of Pediatric Papillary Thyroid Carcinoma.
    Stosic A; Fuligni F; Anderson ND; Davidson S; de Borja R; Acker M; Forte V; Campisi P; Propst EJ; Wolter NE; Chami R; Mete O; Malkin D; Shlien A; Wasserman JD
    Cancer Res; 2021 Nov; 81(22):5625-5637. PubMed ID: 34535459
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Early-Onset Pancreas cancer: Clinical Descriptors, Genomics, and Outcomes.
    Varghese AM; Singh I; Singh R; Kunte S; Chou JF; Capanu M; Wong W; Lowery MA; Stadler ZK; Salo-Mullen E; Saadat LV; Wei AC; Reyngold M; Basturk O; Benayed R; Mandelker D; Iacobuzio-Donahue CA; Kelsen DP; Park W; Yu KH; O'Reilly EM
    J Natl Cancer Inst; 2021 Sep; 113(9):1194-1202. PubMed ID: 33755158
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Mammary analog secretory carcinoma of the thyroid gland: A rare cancer harboring TRK fusion.
    Huang NS; Cao YM; Lu ZW; Guan Q; Chen JY; Ma B; Chen TZ; Bai QM; Wang YL; Ji QH
    Oral Oncol; 2021 Apr; 115():105092. PubMed ID: 33189578
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A Case of Papillary Thyroid Carcinoma and Kostmann Syndrome: A Genomic Theranostic Approach for Comprehensive treatment.
    Han S; Ehrhardt J; Shukla S; Elkbuli A; Nikiforov YE; Gulec SA
    Am J Case Rep; 2019 Jul; 20():1027-1034. PubMed ID: 31308356
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Relationship between genetic alterations and clinicopathological characteristics of papillary thyroid carcinoma.
    Kure S; Wada R; Naito Z
    Med Mol Morphol; 2019 Dec; 52(4):181-186. PubMed ID: 30788603
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Targetable gene fusions identified in radioactive iodine refractory advanced thyroid carcinoma.
    van der Tuin K; Ventayol Garcia M; Corver WE; Khalifa MN; Ruano Neto D; Corssmit EPM; Hes FJ; Links TP; Smit JWA; Plantinga TS; Kapiteijn E; van Wezel T; Morreau H
    Eur J Endocrinol; 2019 Apr; 180(4):235-241. PubMed ID: 30668525
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. MiR-429 suppresses neurotrophin-3 to alleviate perineural invasion of pancreatic cancer.
    Liu D; Song L; Dai Z; Guan H; Kang H; Zhang Y; Yan W; Zhao X; Zhang S
    Biochem Biophys Res Commun; 2018 Nov; 505(4):1077-1083. PubMed ID: 30314698
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase Fusions.
    Vanden Borre P; Schrock AB; Anderson PM; Morris JC; Heilmann AM; Holmes O; Wang K; Johnson A; Waguespack SG; Ou SI; Khan S; Fung KM; Stephens PJ; Erlich RL; Miller VA; Ross JS; Ali SM
    Oncologist; 2017 Mar; 22(3):255-263. PubMed ID: 28209747
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Molecular Characterization of Sporadic Pediatric Thyroid Carcinoma with the DNA/RNA ThyroSeq v2 Next-Generation Sequencing Assay.
    Picarsic JL; Buryk MA; Ozolek J; Ranganathan S; Monaco SE; Simons JP; Witchel SF; Gurtunca N; Joyce J; Zhong S; Nikiforova MN; Nikiforov YE
    Pediatr Dev Pathol; 2016; 19(2):115-22. PubMed ID: 26367451
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Expression of Trk tyrosine kinase receptor is a biologic marker for cell proliferation and perineural invasion of human pancreatic ductal adenocarcinoma.
    Sakamoto Y; Kitajima Y; Edakuni G; Sasatomi E; Mori M; Kitahara K; Miyazaki K
    Oncol Rep; 2001; 8(3):477-84. PubMed ID: 11295066
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.